Use of indocyanine green fluorescence versus patent blue V dye for sentinel lymph node biopsy in early breast cancer, a randomized controlled trial

Muhammad Nida, Ashraf Abdelmoghny, Ahmed G. Osman, Mohammad A. Abd-erRazik, Dina M. Hanafy

Open source

DOI
10.1186/s43046-026-00403-5
Published
2026-09-02
Container
Journal of the Egyptian National Cancer Institute
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s43046-026-00403-5,
  title = {Use of indocyanine green fluorescence versus patent blue V dye for sentinel lymph node biopsy in early breast cancer, a randomized controlled trial},
  author = {Muhammad Nida and Ashraf Abdelmoghny and Ahmed G. Osman and Mohammad A. Abd-erRazik and Dina M. Hanafy},
  year = {2026},
  journal = {Journal of the Egyptian National Cancer Institute},
  doi = {10.1186/s43046-026-00403-5},
  url = {https://doi.org/10.1186/s43046-026-00403-5}
}

RIS

TY  - JOUR
TI  - Use of indocyanine green fluorescence versus patent blue V dye for sentinel lymph node biopsy in early breast cancer, a randomized controlled trial
AU  - Muhammad Nida
AU  - Ashraf Abdelmoghny
AU  - Ahmed G. Osman
AU  - Mohammad A. Abd-erRazik
AU  - Dina M. Hanafy
PY  - 2026
JO  - Journal of the Egyptian National Cancer Institute
DO  - 10.1186/s43046-026-00403-5
UR  - https://doi.org/10.1186/s43046-026-00403-5
ER  - 

APA

Nida, M., Abdelmoghny, A., Osman, A. G., Abd-erRazik, M. A., & Hanafy, D. M. (2026). Use of indocyanine green fluorescence versus patent blue V dye for sentinel lymph node biopsy in early breast cancer, a randomized controlled trial. Journal of the Egyptian National Cancer Institute. https://doi.org/10.1186/s43046-026-00403-5

Source records